Technical testing and analysis
MARINBIOLOGEN AS
Revenue 2024
NOK 425,000
Operating profit
NOK −129,000
Equity
NOK 46,000
Incorporated
2021
Share capital
NOK 30,000
Key figures · 2024
Current ratio
0.97
Equity ratio
30.6%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | -30.4% | |
| Net margin (%%) | -30.3% | |
| Return on assets (%%) | -86.7% | |
| Likviditet | ||
| Current ratio | 0.97 | |
| Working capital | −3k | |
| Soliditet | ||
| Equity ratio (%%) | 30.6% | |
| Debt-to-equity ratio | 2.26 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.